AZD2858

Based on 18 reference(s) in Google Scholar 8 10 18

Axon 3771

CAS [486424-20-8]

MF C21H23N7O3S
MW 453.52

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO
Recently added

AZD2858

Description

Potent and highly selective Glycogen Synthase Kinase-3β (GSK-3β; Ki value 4.9 nM) inhibitor for Alzheimer’s disease with good BBB permeability in a bovine endothelial cell assay. AZD2858 inhibits GSK-3β-mediated tau phosphorylation (IC50 value 76 nM) in vitro, and shows a good overall selectivity versus a panel of 26 kinases and >100 fold selectivity over CDK2 (Ki value 540 nM). In rats, oral AZD2858 treatment caused a dose-dependent increase in trabecular bone mass by GSK-3 mediated inhibition of Wnt canonical signaling, making AZD2858 a possible therapeutic candidate for osteoporosis.

The water-soluble salt form, AZD2858 hydrochloride (Axon 2194), is also available. 

KEYWORDS: AZD2858 | Supplier | GSK-3β inhibitor | AZD-2858 | AZD 2858 | CAS [486424-20-8] | [2108876-05-5] | [486424-21-9] | Non Selective (Phosphorylation substrates) | GSK-3 | Inhibitor | Enzymes | Wnt | osteoporosis | Alzheimer's | AD | amyloid | tau | CDK2 | glycogen | synthase

Order
Size Unit Price Stock
5 mg €95.00 In Stock
25 mg €330.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...